Maternus-Kliniken Aktiengesellschaft (ETR:MAK)
Germany
· Delayed Price · Currency is EUR 1.230
+0.010 (0.81%)
Apr 24, 2025, 5:36 PM CET
ETR:MAK Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Operating Revenue | 108.71 | 102.31 | 106.7 | 111.44 | 114.3 | 124.43 | Upgrade
|
| Revenue | 108.71 | 102.31 | 106.7 | 111.44 | 114.3 | 124.43 | Upgrade
|
| Revenue Growth (YoY) | 6.08% | -4.12% | -4.25% | -2.50% | -8.14% | 0.12% | Upgrade
|
| Cost of Revenue | 90.35 | 90.4 | 90.27 | 82.66 | 86.79 | 99.41 | Upgrade
|
| Gross Profit | 18.35 | 11.9 | 16.43 | 28.78 | 27.51 | 25.02 | Upgrade
|
| Selling, General & Admin | 0.18 | 0.18 | 0.25 | 0.29 | 0.4 | 4.51 | Upgrade
|
| Other Operating Expenses | 9.62 | 11.24 | 15.32 | 16.27 | 15.27 | 13.19 | Upgrade
|
| Operating Expenses | 19.86 | 21.16 | 26.58 | 27.67 | 27.26 | 29.38 | Upgrade
|
| Operating Income | -1.5 | -9.26 | -10.14 | 1.11 | 0.26 | -4.36 | Upgrade
|
| Interest Expense | -8.1 | -7.55 | -5.78 | -6.01 | -7.24 | -8.26 | Upgrade
|
| Interest & Investment Income | 0.26 | 0.16 | 0.05 | 0.08 | 0.08 | 0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.97 | 3.97 | 0.79 | 2.65 | 1.29 | 1.6 | Upgrade
|
| EBT Excluding Unusual Items | -5.37 | -12.69 | -15.08 | -2.17 | -5.61 | -10.98 | Upgrade
|
| Pretax Income | -5.37 | -12.69 | -15.08 | -2.17 | -5.61 | -10.98 | Upgrade
|
| Income Tax Expense | 1.69 | 1.67 | 1.25 | 0.52 | 1.85 | -2.39 | Upgrade
|
| Earnings From Continuing Operations | -7.06 | -14.36 | -16.33 | -2.69 | -7.46 | -8.59 | Upgrade
|
| Minority Interest in Earnings | 0.18 | 0.11 | 2.25 | 0.13 | -2.17 | -1.66 | Upgrade
|
| Net Income | -6.88 | -14.26 | -14.08 | -2.56 | -9.62 | -10.26 | Upgrade
|
| Net Income to Common | -6.88 | -14.26 | -14.08 | -2.56 | -9.62 | -10.26 | Upgrade
|
| Shares Outstanding (Basic) | 21 | 21 | 21 | 21 | 21 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 21 | 21 | 21 | 21 | 21 | 21 | Upgrade
|
| EPS (Basic) | -0.33 | -0.68 | -0.67 | -0.12 | -0.46 | -0.49 | Upgrade
|
| EPS (Diluted) | -0.33 | -0.68 | -0.67 | -0.12 | -0.46 | -0.49 | Upgrade
|
| Free Cash Flow | 13.14 | -1.44 | 2.33 | 15.33 | 11.46 | 15.33 | Upgrade
|
| Free Cash Flow Per Share | 0.63 | -0.07 | 0.11 | 0.73 | 0.55 | 0.73 | Upgrade
|
| Gross Margin | 16.88% | 11.63% | 15.40% | 25.83% | 24.07% | 20.10% | Upgrade
|
| Operating Margin | -1.38% | -9.05% | -9.51% | 1.00% | 0.23% | -3.50% | Upgrade
|
| Profit Margin | -6.33% | -13.94% | -13.19% | -2.30% | -8.42% | -8.24% | Upgrade
|
| Free Cash Flow Margin | 12.08% | -1.41% | 2.19% | 13.76% | 10.02% | 12.32% | Upgrade
|
| EBITDA | 2.01 | -6.06 | -6.95 | 4.25 | 3.47 | -0.89 | Upgrade
|
| EBITDA Margin | 1.85% | -5.92% | -6.52% | 3.81% | 3.04% | -0.72% | Upgrade
|
| D&A For EBITDA | 3.51 | 3.2 | 3.19 | 3.14 | 3.21 | 3.47 | Upgrade
|
| EBIT | -1.5 | -9.26 | -10.14 | 1.11 | 0.26 | -4.36 | Upgrade
|
| EBIT Margin | -1.38% | -9.05% | -9.51% | 1.00% | 0.23% | -3.50% | Upgrade
|
| Revenue as Reported | 120.01 | 114.94 | 114.29 | 119.65 | 118.23 | 129.34 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.